$GSK
SEC EDGAR Filings Hub
2 Filings
$GSK · GSK plc SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for GSK plc ($GSK) from October 26, 2026 through October 28, 2026, including 0 Form 10-K annual reports, 0 Form 10-Q quarterly earnings reports, 0 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
Check $GSK portfolio concentration →
View $GSK Congress trades →
Research $GSK stock →
All SEC filings →
Total Filings2
10-K / 10-Q Reports0
8-K Material Events0
Form 4 Insider0
High-Impact1
Latest FilingOctober 28, 2026
Browse SEC Filings by Form Type
Latest $GSK SEC Filings & AI Summaries (2)
October 28, 2026
$GSK 6-K — GSK plc
GSK's Specialty Medicines engine is firing (+15% CER) but heavy restructuring costs and R&D spend are compressing bottom-line conversion, leaving the stock vulnerable despite re…
October 26, 2026
$GSK 6-K — GSK plc
The 76% complete response rate with no recurrences after 2+ years supports an organ-preservation paradigm that could eliminate chemo, radiation, and surgery for a subset of rect…
Related & Peer Company SEC Filing Hubs